Tutkimukseen otetaan potilaan suostumuksella alle 65-vuotiaita avosydänleikkauk-seen joko koronaariohitus- tai sydämen läppärekonstruktioon tulevia potilaita, jotka leikatataan perfuusioleikkauksena. MedDRA version: 9.1 Level: LLT Classification code 10011099 Term: Coronary disease MedDRA version: 9.1 Level: LLT Classification code 10002906 Term: Aortic stenosis MedDRA version: 9.1 Level: LLT Classification code 10027716 Term: Mitral insufficiency
Conditions
Interventions
Trade Name: Lyrica
Pharmaceutical Form:
INN or Proposed INN: PREGABALIN
CAS Number: 148553508
Pharmaceutical form of the placebo: Capsule, soft
Route of administration of the placebo: Oropharyngeal u
Sponsors
Organisation name was not entered
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: ;Secondary Objective: ;Primary end point(s): | — |
Countries
Finland
Outcome results
None listed